Table 2.
Differential metabolites in the liver and their change trends among groups.
No. | Differential Metabolites | Mode | CYP vs. NC | MP+CYP vs. CYP | ||||
---|---|---|---|---|---|---|---|---|
VIP | FC | Trend | VIP | FC | Trend | |||
1 | Glycerophosphocholine | ESI+ | 1.66 | 0.80 | ↓ * | 1.08 | 1.08 | ↑ * |
2 | LysoPA(18:1(9Z)/0:0) | ESI− | 1.2 | 0.71 | ↓ * | 1.69 | 1.27 | ↑ * |
3 | 4-Trimethylammoniobutanoic acid | ESI+ | 1.11 | 0.72 | ↓ * | 1.60 | 1.42 | ↑ * |
4 | Uridine | ESI+ | 2.07 | 0.82 | ↓ ** | 1.29 | 1.18 | ↑ * |
5 | Orotidine | ESI− | 2.22 | 0.71 | ↓ *** | 1.37 | 1.37 | ↑ * |
6 | S-Adenosylhomocysteine | ESI+ | 2.05 | 0.75 | ↓ * | 1.06 | 1.30 | ↑ * |
7 | L-Methionine | ESI+ | 1.58 | 0.88 | ↓ * | 1.70 | 1.17 | ↑ * |
8 | Uracil | ESI− | 1.82 | 1.24 | ↓ * | 1.12 | 1.02 | ↑ * |
9 | LysoPC(20:4(8Z,11Z,14Z,17Z)) | ESI+ | 1.95 | 1.67 | ↑ * | 1.71 | 0.64 | ↓ * |
10 | Deoxycytidine | ESI− | 1.84 | 0.76 | ↑ * | 1.20 | 0.76 | ↓ * |
11 | 8,9-DiHETrE | ESI− | 1.59 | 1.63 | ↑ * | 1.16 | 0.70 | ↓ * |
12 | 2-Amino-3,8-dimethyl-3H-imidazo [4,5-f]quinoxaline | ESI+ | 2.45 | 2.24 | ↑ *** | 2.37 | 0.43 | ↓ *** |
13 | Ribose 1-phosphate | ESI− | 1.47 | 1.33 | ↑ * | 1.58 | 0.74 | ↓ * |
14 | PC(16:1(9Z)/16:1(9Z)) | ESI+ | 1.19 | 2.23 | ↑ * | 1.57 | 0.36 | ↓ * |
15 | Tetraacetylethylenediamine | ESI+ | 2.14 | 2.25 | ↑ *** | 2.56 | 0.35 | ↓ *** |
16 | D-4′-Phosphopantothenate | ESI+ | 1.38 | 1.53 | ↑ * | 1.67 | 0.62 | ↓ * |
17 | PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)) | ESI+ | 1.45 | 1.29 | ↑ * | 1.75 | 0.75 | ↓ * |
18 | Saccharopine | ESI− | 2.55 | 2.16 | ↑ *** | 2.47 | 0.40 | ↓ *** |
19 | N-Acetylglutamic acid | ESI− | 1.77 | 1.27 | ↑ * | 2.33 | 0.68 | ↓ *** |
20 | Sedoheptulose | ESI+ | 1.27 | 1.79 | ↑ * | 1.99 | 0.42 | ↓ ** |
21 | Homocitrulline | ESI+ | 1.71 | 1.36 | ↑ * | 1.77 | 0.66 | ↓ * |
* p < 0.05, ** p < 0.01, *** p < 0.0001. The arrow (↑ and ↓) means the changing trend of biomarkers between groups.